UAE – State-owned Dubai Academic Health Corporation (DAHC), AXDEV Group, and Pfizer have signed a public-private partnership for improving chronic disease management. It follows the emerging trends of world-class healthcare…
Read MoreTag: Pfizer
Pfizer recalls over 4 million packages of prescription migraine medicine voluntarily
USA — Pfizer has issued a recall for 4.2 million packages of Nurtec ODT, which is used to treat migraines in adults. The U.S. Consumer Product Safety Commission (CPSC) raised…
Read MoreFDA advisory panel supports full approval of Pfizer’s COVID therapy
USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of severe disease…
Read MorePfizer, Biovac launch freezer farm facility for vaccine storage and supply
SOUTH AFRICA – Pfizer and Biovac have launched a freezer farm facility which will serve as an ultracold storage facility and add to the institute’s capacity for vaccine storage and…
Read MorePfizer’s Zavzpret nasal spray granted FDA approval for migraine treatment
USA — The U.S. Food and Drug Administration (FDA) has approved Pfizer’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. As the first…
Read MorePfizer to acquire Seagen for US$43B in long-awaited M&A deal
USA —Pfizer has agreed to acquire Seagen, a Seattle-based biotechnology company that develops novel tumor-killing medicine, for US$43 billion in one of the biggest deals in the biotech industry in…
Read MorePfizer and GSK on track to release highly anticipated RSV vaccines this year
USA —According to recent reports by Reuters, Pfizer, a US-based pharmaceutical company, has developed a vaccine for respiratory syncytial virus (RSV) and is prepared to launch it pending regulatory approval.…
Read MorePfizer partners with Samsung Bio for drug substance manufacturing until 2029
SOUTH KOREA — Samsung Biologics, a contract development and manufacturing organization (CDMO), has signed a biologics supply contract with pharma giant Pfizer worth KRW 241 billion (US$183 million) and it…
Read MoreViolations of Good Clinical Practices force Pfizer and Valneva to halve number of participants in Lyme disease vaccine trial
USA — Pfizer and Valneva are dropping roughly half of the 7,000 total participants enrolled in the Phase III trial of the experimental Lyme disease vaccine VLA15 in the U.S.…
Read MorePfizer retains EU Parliament access amid vaccine purchase controversy
BELGIUM — Pfizer representatives will maintain their access to the European Parliament, despite facing possible expulsion amidst the ongoing controversy surrounding the purchase of COVID-19 vaccines. According to EurActiv, the…
Read More